ATOS has been a quiet performer in my portfolio so far. Had positive news recently with the Phase 2 study of Endoxifen as well as it's inclusion in the Russell 2000 and 3000 indexes.
I'm hoping to see further strength in it's performance in the future.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
暂无评论